We provide diagnostic solutions which determine the source of disease & contamination to improve patient health & ensure consumer safety #PioneeringDiagnostics" title="" class="btn" data-container="body" data-html="true" data-id="59708" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="bioMérieux"> 15,306 1,684 270 1,115 343,253
Sectors
Location
100 All. Louis Raymond, 69280 Marcy-l'Étoile, France
Marcy-l'Étoile
France
SIREN
673620399Engaged entities
443Added in Motherbase
18 Sep 2019, 4:49 p.m.Pioneering Diagnostics
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.
In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.
bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.
Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
bioMérieux is listed on the Euronext Paris stock market.
Symbol: BIM – ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP
in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis
Pioneering Diagnostics
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.
In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.
bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.
Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
bioMérieux is listed on the Euronext Paris stock market.
Symbol: BIM – ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP
bioMérieux | Pioneering Diagnostics
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | C-Therm Technologies Ltd. Research Services, deeptech | Other | ||
![]() | Mérieux NutriSciences - France Biotechnology Research, healthtech, it services | Other 3 Feb 2025 | | |
![]() | DataM Intelligence Market Research | Other 5 Feb 2025 | | |
![]() | Delta Consultants - Full-service CRO Pharmaceutical Manufacturing, it services | Other 30 Jan 2025 | | |
![]() | Association IRSAM Civic and Social Organizations, healthtech | Other 31 Jan 2025 | | |
![]() | TeamsConnect Events Services, it services | Other 24 Jan 2025 | | |
![]() | Neovision IT Services and IT Consulting, deeptech | Other 17 Jan 2025 | | |
![]() | IUT Lyon 1 Higher Education, edtech | Other 24 Jan 2025 | | |
![]() | Pasteur Foundation - UK healthtech | Other 30 Nov 2024 | | |
![]() | Nucleate France UniCA it services | Other 9 Jan 2025 | |